Atlas Trials

Study to Evaluate the Improvement Effect on Subjective Symptom of FEXUCLUE Tab

Clinical trial NCT05614752 · COMPLETED

Trial details

NCT number
NCT05614752
Sponsor
Daewoong Pharmaceutical Co. LTD.
Status
COMPLETED
Study type
OBSERVATIONAL
Gastroesophageal Reflux Disease
Start date
2022-07-06
Primary completion
2023-12-31
Enrollment
10067

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.